X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2821) 2821
Book Review (468) 468
Publication (138) 138
Book Chapter (39) 39
Dissertation (13) 13
Conference Proceeding (8) 8
Magazine Article (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1775) 1775
β-blockers (1446) 1446
humans (1323) 1323
β-blocker (945) 945
beta-blockers (874) 874
male (866) 866
female (717) 717
adrenergic beta-antagonists - therapeutic use (657) 657
middle aged (569) 569
beta-blocker (520) 520
pharmacology & pharmacy (443) 443
aged (437) 437
cardiac & cardiovascular systems (418) 418
animals (394) 394
adult (373) 373
hypertension (373) 373
heart failure (332) 332
adrenergic beta-antagonists - pharmacology (313) 313
hypertension - drug therapy (264) 264
propranolol (243) 243
treatment outcome (238) 238
blood pressure - drug effects (236) 236
mortality (229) 229
carvedilol (228) 228
metoprolol (221) 221
heart rate - drug effects (195) 195
adrenergic beta-antagonists - administration & dosage (194) 194
heart failure - drug therapy (194) 194
peripheral vascular disease (189) 189
chemistry, analytical (185) 185
adrenergic beta-antagonists - adverse effects (175) 175
rats (165) 165
risk factors (156) 156
atenolol (155) 155
antihypertensive agents - therapeutic use (153) 153
therapy (141) 141
propanolamines - therapeutic use (139) 139
time factors (134) 134
diuretics (118) 118
prospective studies (118) 118
abridged index medicus (117) 117
retrospective studies (116) 116
double-blind method (115) 115
aged, 80 and over (113) 113
myocardial infarction (112) 112
dose-response relationship, drug (110) 110
drug therapy, combination (108) 108
angiotensin-converting enzyme inhibitors - therapeutic use (106) 106
biochemical research methods (104) 104
β‐blockers (104) 104
carbazoles - therapeutic use (103) 103
drugs (102) 102
hypertension - physiopathology (102) 102
propanolamines - pharmacology (102) 102
management (101) 101
metoprolol - therapeutic use (100) 100
follow-up studies (97) 97
heart rate (96) 96
myocardial-infarction (96) 96
heart failure - physiopathology (95) 95
propranolol - pharmacology (95) 95
blockers (91) 91
hemodynamics - drug effects (91) 91
risk (88) 88
nebivolol (87) 87
cardiovascular (86) 86
prognosis (85) 85
dilated cardiomyopathy (84) 84
blood pressure (83) 83
blood-pressure (83) 83
drug therapy (83) 83
analysis (81) 81
survival (81) 81
prevention (80) 80
double-blind (79) 79
acute myocardial-infarction (77) 77
adrenergic beta-antagonists - chemistry (77) 77
calcium channel blockers (77) 77
chronic heart-failure (75) 75
disease (75) 75
medicine, general & internal (75) 75
adolescent (74) 74
cardiovascular disease (74) 74
beta blockers (73) 73
calcium channel blockers - therapeutic use (72) 72
care and treatment (72) 72
β blockers (71) 71
medicine & public health (70) 70
glaucoma (69) 69
trial (69) 69
myocardial infarction - drug therapy (68) 68
ace inhibitors (67) 67
atenolol - therapeutic use (67) 67
angiotensin-converting enzyme inhibitors (66) 66
antihypertensive agents - adverse effects (66) 66
electrocardiography (65) 65
article (63) 63
heart-failure (63) 63
stereoisomerism (63) 63
β‐blocker (63) 63
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2666) 2666
Japanese (83) 83
German (31) 31
French (15) 15
Polish (15) 15
Chinese (14) 14
Slovak (14) 14
Spanish (13) 13
Korean (8) 8
Italian (5) 5
Portuguese (5) 5
Russian (5) 5
Czech (2) 2
Hungarian (2) 2
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Catalysis Today, ISSN 0920-5861, 02/2019, Volume 323, pp. 14 - 25
The photocatalytic degradation of β-blockers in TiO was investigated. Metoprolol (MET) was selected as a model compound since its structure is quite similar to... 
Photocatalytic degradation | Metoprolol | Reaction mechanism | β-blockers
Journal Article
Chest, ISSN 0012-3692, 06/2018, Volume 153, Issue 6, pp. 1315 - 1325
Cardiovascular disease is a frequent comorbidity in patients with COPD. Many physicians, particularly pulmonologists, are reluctant to use β-adrenoceptor... 
β-blockers | lung function | safety | COPD
Journal Article
Journal of Thoracic and Cardiovascular Surgery, ISSN 0022-5223, 2019
Objective: The objective of the study was to evaluate the effects of β-blocker therapy on long-term outcomes in patients after surgical repair of type A aortic... 
late outcomes | type A aortic dissection | β-blockers | surgery
Journal Article
Journal of Chromatography A, ISSN 0021-9673, 05/2007, Volume 1148, Issue 2, pp. 158 - 167
A method using solid-phase extraction (SPE) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been developed for the determination of 12... 
LC-MS/MS | Agonists | Sewage | β-Blockers | Solid-phase extraction
Journal Article
Journal of geriatric cardiology : JGC, ISSN 1671-5411, 03/2019, Volume 16, Issue 3, pp. 291 - 297
β-blocker (BB) therapy is a cornerstone for the treatment of coronary heart disease (CHD). The evidence of the benefit from long-term BB therapy in diabetic... 
β-blockers | Diabetes | MACE | Cardiovascular mortality
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 2014, Volume 73, pp. 308 - 317
Hypertension induces left-ventricular hypertrophy (LVH) by mechanisms involving oxidative stress and unbalanced cardiac matrix metalloproteinase (MMP)... 
Hypertension | Oxidative stress | Free radicals | MMP-2 | Cardiac remodeling | β-Blockers
Journal Article
Vascular Health and Risk Management, ISSN 1176-6344, 2008, Volume 4, Issue 1, pp. 23 - 30
Journal Article
Quimica Nova, ISSN 0100-4042, 2014, Volume 37, Issue 8, pp. 1342 - 1350
Journal Article
Journal of Hazardous Materials, ISSN 0304-3894, 02/2017, Volume 323, Issue Pt A, pp. 250 - 263
Metoprolol is a β-blocker highly prescribed for the treatment of heart diseases. It is not efficiently removed in wastewater treatment plants and it has been... 
HPLC–MS | Photodegradation | Degradation products | Metoprolol | β-Blockers | Natural fulvic acids
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 16, pp. 1639 - 1648
Abstract Objectives This study sought to examine predictors, trends, and outcomes associated with β-blocker prescriptions at discharge in patients with stable... 
Cardiovascular | percutaneous coronary intervention | stable angina | β-blockers
Journal Article
Bûlleten' Sibirskoj Mediciny, ISSN 1682-0363, 11/2018, Volume 9, Issue 4, pp. 89 - 93
In the experiment on rabbits were presents, that experimental arterial hypertension didn’t led to functional failure of lymphatic drainage of brain. On the... 
CNS | β-blockers | adrenaline | lymphatic node
Journal Article
Journal Article
Journal of Clinical Pharmacology, ISSN 0091-2700, 02/2008, Volume 48, Issue 2, pp. 225 - 239
Beta-blockers are well-established therapeutic agents in the treatment of hypertension and cardiovascular disease. However, these agents are highly... 
Nebivolol | Pharmacodynamics | β-blockers | Pharmacokinetics | Nitric oxide
Journal Article
Patient Preference and Adherence, ISSN 1177-889X, 08/2016, Volume 2016, Issue Issue 1, pp. 1461 - 1469
Snežana Mugoša,1,2 Nataša Djordjević,3 Nina Djukanović,4 Dragana Protić,5 Zoran Bukumirić,6 Ivan Radosavljević,7 Aneta Bošković,8 Zoran Todorović5,9... 
adverse drug reactions | CYP2D6 | β-blockers | pharmacogenetics
Journal Article
Clinical Medicine Insights. Oncology, ISSN 1179-5549, 2019, Volume 13, pp. 1179554919835798 - 1179554919835798
Lung cancer is the leading cause of cancer-related mortality and is strongly linked with smoking. We sought to determine whether major stressful life events... 
Journal Article
Asian Journal of Pharmaceutical and Clinical Research, ISSN 0974-2441, 12/2018, Volume 11, Issue 12, pp. 416 - 420
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2010, Volume 127, Issue 1, pp. S1 - S55
Journal Article